We are live on ! Find out more
JJIJ

Johnson & Johnson Innovation - JJDC Portfolio holdings

AUM $978M
1-Year Est. Return 102.17%
This Fund
S&P 500
This Quarter Est. Return
-41.36%
1 Year Est. Return
+102.17%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$93.6M
Cap. Flow
+$49M
Cap. Flow %
26.64%
Top 10 Hldgs %
99.79%
Holding
12
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MGTX icon
MeiraGTx Holdings
MGTX
+$49M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.68%
2 Technology 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$11.8B
$93.8M 51.06%
3,260,869
– –
MGTX icon
2
MeiraGTx Holdings
MGTX
$1.1B
$39M 21.2%
+2,898,550
New +$49M
PTGX icon
3
Protagonist Therapeutics
PTGX
$8.7B
$17.3M 9.41%
2,449,183
– –
PHGE icon
4
BiomX
PHGE
$1.94M
$14.9M 8.13%
11,228
– –
PRVB
5
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$10.3M 5.63%
1,124,973
– –
PHAS
6
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$5.32M 2.89%
1,607,044
– –
ALDX icon
7
Aldeyra Therapeutics
ALDX
$94.7M
$1.47M 0.8%
594,834
– –
CSLT
8
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$587K 0.32%
811,295
– –
SENS icon
9
Senseonics Holdings Inc
SENS
$256M
$333K 0.18%
26,282
– –
GYRE icon
10
Gyre Therapeutics
GYRE
$675M
$293K 0.16%
8,927
– –
GNCA
11
DELISTED
Genocea Biosciences, Inc.
GNCA
$248K 0.14%
143,964
– –
TCON
12
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$143K 0.08%
4,200
– –

Similar funds

NNP
Nachman Norwood & Parrott Greenville, South Carolina $984M AUM 33.8% 1-Year Est. Return
BAWC
Black-and-white Capital Los Angeles, California $967M AUM 94.03% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
NIA
Northstar Investment Advisors Denver, Colorado $755M AUM 37.8% 1-Year Est. Return
SCM
Snow Capital Management Sewickley, Pennsylvania $703M AUM 76.26% 1-Year Est. Return
EMG
Ellington Management Group Old Greenwich, Connecticut $676M AUM 23.65% 1-Year Est. Return
APA
Allegiant Private Advisors Sarasota, Florida $618M AUM
HFA
Hoover Financial Advisors Malvern, Pennsylvania $562M AUM 37.9% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's Q1 2020 Portfolio in Review

As of Q1 2020, Johnson & Johnson Innovation - JJDC held 12 positions worth $184M, down 34% from $277M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Johnson & Johnson Innovation - JJDC deployed $49M of net new capital in Q1 2020, opening 1 new position. Its largest new stake was MeiraGTx Holdings: 2,898,550 shares worth $39M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Technology.

  • Johnson & Johnson Innovation - JJDC's largest Q1 2020 buy was MeiraGTx Holdings: 2,898,550 shares worth $39M.
  • Johnson & Johnson Innovation - JJDC's ten largest holdings make up 100% of its $184M portfolio in Q1 2020.
  • Johnson & Johnson Innovation - JJDC opened 1 new position and closed 0 in Q1 2020.
  • Johnson & Johnson Innovation - JJDC's portfolio value fell 34% quarter-over-quarter to $184M.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q1 2020, filed 13 May 2020.